In this GEN webinar, sponsored by 908 Devices, our presenters will walk us through the fundamentals surrounding new cutting-edge technology that can perform rapid analysis straight from the lab bench.
In this roundtable hear from four distinguished experts as they critically weigh the benefits of working with a manufacturing partner. This roundtable, sponsored by Catalent, is a must-see for early and late-stage cell therapy innovator companies who are considering a manufacturing partnership.
A large proportion of initially promising biotherapeutic candidates never make it to commercialization. It is critical to evaluate potential liabilities as early as possible during molecule design and utilize lead selection phases to increase the chances of identifying a successful candidate significantly. It is also essential that the best approaches and tools are selected to maximize success when moving the selected candidate through development. In this GEN webinar, we will introduce strategies and tools to increase the chance of success through both of these stages.
In the March episode of GEN Live, we are thrilled to welcome Walter Isaacson, who gives one of his first in-depth interviews on his new book The Code Breaker, published this month. We’ll talk to Walter about his impressions of Doudna and other key members of the CRISPR community, the impact of COVID-19, the role of innovation in science, and other adventures in gene editing and storytelling.
In this GEN Webinar, sponsored by Snthesis, we will hear about the challenges facing research teams as they work to curate large omics data sets in preparation for analysis. We will then explore modern strategies and technical approaches that can dramatically simplify and improve the process.
In this GEN webinar, sponsored by Horizon, we will hear about the gene-editing tools and options available at Horizon Discovery to customize the CHO expression host for both research and commercial use to suit specific needs during discovery, development, and protein production.
In this GEN webinar, sponsored by PerkinElmer, our distinguished presenters will provide perspectives on how the gene therapy field ought to evolve. From the early vector systems, which often represented replicating viruses, to the recent sophisticated engineering of targeted virus driven cell and gene therapies that have demonstrated clinical benefits and gained FDA approval for multiple diseases.
In this GEN webinar, sponsored by Aldevron and Synthego, we will hear how the Wilson lab works to advance this approach by performing molecular engineering, giving CRISPR enzymes the properties necessary for safe, efficient, and accessible delivery in a clinical setting. These efforts will enable in vivo delivery of CRISPR enzymes, including hard-to-deliver tools such as base editors and prime editors.
In this GEN webinar, sponsored by PerkinElmer, we will find out about an exciting protein characterization system that addresses many of the challenges researchers face during vaccine development projects. We will also learn about key applications of microfluidic chip-capillary electrophoresis in vaccine process development.
Join this GEN webinar, sponsored by Thermo Fisher Scientific, and learn more on novel purification solutions that can help accelerate early vaccine candidate screening and improve the downstream process of different vaccine modalities such as mRNA, recombinant proteins, and Virus-Like Particles (VLPs). In addition, a new scavenging method for the removal of Baculovirus process impurities will be presented.